0001482981-24-000091.txt : 20240618 0001482981-24-000091.hdr.sgml : 20240618 20240618192626 ACCESSION NUMBER: 0001482981-24-000091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van Es Charles CENTRAL INDEX KEY: 0001886344 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40950 FILM NUMBER: 241053591 MAIL ADDRESS: STREET 1: C/O THE VITA COCO COMPANY, INC. STREET 2: 250 PARK AVENUE SOUTH, SEVENTH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vita Coco Company, Inc. CENTRAL INDEX KEY: 0001482981 STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 113713156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 250 PARK AVENUE SOUTH STREET 2: SEVENTH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 212-206-0763 MAIL ADDRESS: STREET 1: 250 PARK AVENUE SOUTH STREET 2: SEVENTH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 FORMER COMPANY: FORMER CONFORMED NAME: All Market Inc. DATE OF NAME CHANGE: 20210824 FORMER COMPANY: FORMER CONFORMED NAME: All Market, Inc. DATE OF NAME CHANGE: 20210824 FORMER COMPANY: FORMER CONFORMED NAME: Vita Coco Company, Inc. DATE OF NAME CHANGE: 20210823 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-06-14 0 0001482981 Vita Coco Company, Inc. COCO 0001886344 van Es Charles 250 PARK AVE SOUTH SEVENTH FLOOR NEW YORK NY 10003 0 1 0 0 Chief Sales Officer 1 Common Stock 2024-06-14 4 M 0 2805 10.178 A 100473 D Common Stock 2024-06-14 4 S 0 2805 30.06 D 97668 D Common Stock 2024-06-17 4 M 0 6700 10.178 A 104368 D Common Stock 2024-06-17 4 S 0 6700 30.04 D 97668 D Common Stock 2024-06-18 4 M 0 6123 10.178 A 103791 D Common Stock 2024-06-18 4 S 0 6123 30.009 D 97668 D Non-Qualified Stock Option (right to buy) 10.178 2024-06-14 4 M 0 2805 0.0 D 2029-12-16 Common Stock 2805 36870 D Non-Qualified Stock Option (right to buy) 10.178 2024-06-17 4 M 0 6700 0.0 D 2029-12-16 Common Stock 6700 30170 D Non-Qualified Stock Option (right to buy) 10.178 2024-06-18 4 M 0 6123 0.0 D 2029-12-16 Common Stock 6123 24047 D Non-Qualified Stock Option (right to buy) 10.178 2030-02-10 Common Stock 113750 113750 D Non-Qualified Stock Option (right to buy) 10.178 2031-01-11 Common Stock 27300 27300 D Non-Qualified Stock Option (right to buy) 15.0 2031-10-21 Common Stock 58043 58043 D Non-Qualified Stock Option (right to buy) 15.36 2032-08-15 Common Stock 42980 42980 D Non-Qualified Stock Option (right to buy) 16.91 2033-03-10 Common Stock 14205 14205 D Non-Qualified Stock Option (right to buy) 26.18 2034-03-04 Common Stock 8746 8746 D The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.34, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in two equal installments on January 11, 2023 and January 11, 2025. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. By: Yolanda Goettsch, Attorney-in-Fact For: Charles van Es 2024-06-18